Botulinum Toxin Type A

Known as: Clostridium Botulinum Toxin Type A, BoNT/A, Botulinum Toxins, Type A 
An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular… (More)
National Institutes of Health

Related topics

Related topics

42 relations
Anal FissureBlepharospasmBotulinum Toxin Type A InjectionClostridium botulinum toxin A Ab:PrThr:Pt:Ser:Ord
(More)

Narrower (13)

BotoxDWP450DysportHengli BTX-A
(More)

Broader (3)

Botulinum ToxinsNeuromuscular AgentsNeurotoxins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
OBJECTIVE Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
SV2 is the protein receptor for botulinum neurotoxin A.
How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
OBJECTIVES To determine the effect of botulinum toxin type A on calcitonin gene-related peptide secretion from cultured… (More)
Is this relevant?
Review
2003
Review
2003
Evidence for antinociceptive activity of botulinum toxin type A in pain management.
The neurotoxin, botulinum toxin type A, has been used successfully, in some patients, as an analgesic for myofascial pain… (More)
Is this relevant?
Review
2000
Review
2000
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
Botulinum toxin type A (BTX-A) is increasingly being used for the treatment of childhood spasticity, particularly cerebral palsy… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
OBJECTIVE The object of this clinical experience was to evaluate the correlation between pericranial botulinum toxin type A… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
OBJECTIVE To assess the safety and efficacy of botulinum toxin type A (BOTOX; Allergan, Inc) in the prevention of migraine… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
Spasticity is a disorder of excess muscle tone associated with CNS disease. We hypothesized that botulinum toxin, a neuromuscular… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
NEUROTRANSMITTER release is potently blocked by a group of structurally related toxin proteins produced by Clostridium botulinum1… (More)
Is this relevant?